NASDAQ:NVCR
NovoCure Limited Stock News
$16.47
+0.340 (+2.11%)
At Close: May 10, 2024
3 Beaten-Down Stocks That Could Deliver 5X Gains By 2030
06:02am, Monday, 02'nd May 2022
These stocks are losers now. But they could be huge winners over the next few years.
Novocure (NVCR) Q1 2022 Earnings Call Transcript
05:30pm, Thursday, 28'th Apr 2022 The Motley Fool
NVCR earnings call for the period ending March 31, 2022.
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
12:52pm, Thursday, 28'th Apr 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Moderna Seeks FDA Emergency Use Nod For COVID-19 Shot In Kids 2-6
Moderna Inc (NASDAQ: MRNA) submitt
NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
12:35pm, Thursday, 28'th Apr 2022 Zacks Investment Research
NovoCure (NVCR) delivered earnings and revenue surprises of 76.47% and 1.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
NovoCure Limited's (NVCR) Management on Q1 2022 Results - Earnings Call Transcript
12:30pm, Thursday, 28'th Apr 2022
NovoCure Limited (NASDAQ:NVCR ) Q1 2022 Earnings Conference Call April 28, 2022 8:00 AM ET Company Participants Ingrid Goldberg – Investor Relations Bill Doyle – Executive Chairman Ashley Cordova
NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
09:49am, Thursday, 28'th Apr 2022
NovoCure (NVCR) delivered earnings and revenue surprises of 76.47% and 1.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The FDA Will Soon Give These 3 Healthcare Companies the Green Light
08:00pm, Friday, 22'nd Apr 2022 The Motley Fool
These Fool.com contributors see happy news in the future for Novavax, Axsome Therapeutics, and Novocure.
The FDA Will Soon Give These 3 Healthcare Companies the Green Light
04:00pm, Friday, 22'nd Apr 2022
These Fool.com contributors see happy news in the future for Novavax, Axsome Therapeutics, and Novocure.
Clearbridge Small Cap Strategy Portfolio Manager Commentary Q1 2022
04:10am, Friday, 15'th Apr 2022 Seeking Alpha
ClearBridge Small Cap Strategy outperformed its Index benchmark during Q1. Who were the leading detractors and contributors? Click here to find out.
3 Stocks That Could Realistically Turn $300,000 Into $1 Million by 2030
09:52am, Thursday, 14'th Apr 2022 The Motley Fool
There are clear paths for all of these companies to deliver huge returns to shareholders this decade.
2 Under-the-Radar Biotech Stocks to Buy in 2022
03:30pm, Monday, 11'th Apr 2022 The Motley Fool
Both companies have catalysts for explosive growth this year.
2 Under-the-Radar Biotech Stocks to Buy in 2022
11:30am, Monday, 11'th Apr 2022
Both companies have catalysts for explosive growth this year.
This Up-and-Coming Healthcare Stock Could Skyrocket
10:00am, Friday, 08'th Apr 2022 The Motley Fool
Can Novocure gain widespread acceptance by physicians?
3 Growth Stocks to Buy With $1,000 Right Now
09:55am, Friday, 08'th Apr 2022 The Motley Fool
Their growth opportunities are simply too great to ignore.
This Up-and-Coming Healthcare Stock Could Skyrocket
06:00am, Friday, 08'th Apr 2022
Can Novocure gain widespread acceptance by physicians?
